Skip to main content
. 2020 Oct 13;12(10):2960. doi: 10.3390/cancers12102960

Figure 6.

Figure 6

An immune-related gene signature, based on GASC study, could predict GBM prognosis. The prognostic value of CCL2, CXCL2, IL8, SPP1 and TGFB1 was assessed independently in the TCGA-GBM RNA-seq dataset and was represented by Kaplan-Meier plots. Both the (A) Overall Survival (OS, left panel) and the (B) Disease-Free Survival (DFS, right panel) were evaluated. Afterwards, the analysis was repeated considering the five-genes signature (median expression). Patients were stratified based on the optimal cut-point and data were censored at 24 months for OS and at 12 months for DFS.